Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
Combinations of a cyclooxygenase-2 inhibitor and a leukotriene A 4 hydrolase inhibitor are described for treatment of inflammation and inflammation-related disorders.